| 18th May 2021 11:08 am |
RNS |
Final Results |
| 7th May 2021 7:00 am |
RNS |
TLSA interview on Bloomberg TV on 8th May 2021 |
| 5th May 2021 7:45 am |
RNS |
TLSA Strategic Initiative with Takanawa Japan K.K. |
| 27th Apr 2021 7:00 am |
RNS |
B. Riley Virtual Neuroscience Investor Conference |
| 13th Apr 2021 12:00 pm |
RNS |
Tiziana Announces Plans to List Accustem in US |
| 30th Mar 2021 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 30th Mar 2021 4:36 pm |
RNS |
Price Monitoring Extension |
| 30th Mar 2021 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 30th Mar 2021 2:00 pm |
RNS |
Price Monitoring Extension |
| 30th Mar 2021 1:00 pm |
RNS |
FDA Allows Foralumab Treatment for a SPMS Patient |
| 30th Mar 2021 12:30 pm |
RNS |
Accustem Update |
| 30th Mar 2021 7:00 am |
RNS |
P2 Study in Moderate to Severe Covid-19 Patients |
| 29th Mar 2021 1:02 pm |
RNS |
Updated: Gabriele Cerrone, Bloomberg Interview |
| 29th Mar 2021 7:00 am |
RNS |
Chairman of Tiziana to give interview on Bloomberg |
| 26th Feb 2021 7:00 am |
RNS |
Tiziana Interview to Air on Bloomberg TV |
| 16th Feb 2021 2:37 pm |
RNS |
Tiziana at BIO CEO & Investor Digital Conference |
| 5th Feb 2021 7:10 am |
RNS |
Director/PDMR Shareholding |
| 5th Feb 2021 7:00 am |
RNS |
APPOINTMENT OF DIRECTOR |
| 3rd Feb 2021 7:00 am |
RNS |
CEO exclusive interview to discuss COVID-19 Trial |
| 2nd Feb 2021 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 2nd Feb 2021 4:36 pm |
RNS |
Price Monitoring Extension |
| 2nd Feb 2021 9:05 am |
RNS |
Second Price Monitoring Extn |
| 2nd Feb 2021 9:00 am |
RNS |
Price Monitoring Extension |
| 2nd Feb 2021 7:00 am |
RNS |
Positive Data: Nasal Administration of Foralumab |
| 27th Jan 2021 7:00 am |
RNS |
Tiziana files F-3 Statement with U.S. SEC |
| 26th Jan 2021 7:00 am |
RNS |
Updated corporate presentation |
| 20th Jan 2021 11:04 am |
RNS |
B. Riley Virtual Oncology Investor Conference |
| 20th Jan 2021 7:00 am |
RNS |
AIM Delisting and Admission to the Main Market |
| 13th Jan 2021 7:00 am |
RNS |
Appointment of Chief Medical Officer |
| 11th Jan 2021 4:46 pm |
RNS |
Tiziana at J.P. Morgan Healthcare Conference 2021 |
| 11th Jan 2021 2:48 pm |
RNS |
Tiziana to Present at Biotech Showcase Digital |
| 4th Jan 2021 9:05 am |
RNS |
Second Price Monitoring Extn |
| 4th Jan 2021 9:00 am |
RNS |
Price Monitoring Extension |
| 4th Jan 2021 7:00 am |
RNS |
Completion of Foralumab Clinical Trial in Brazil |
| 18th Dec 2020 11:13 am |
RNS |
Publication of Prospectus |
| 17th Dec 2020 3:00 pm |
RNS |
Notification of Admission to the Main Market |
| 10th Dec 2020 7:00 am |
RNS |
Director/PDMR Shareholding |
| 1st Dec 2020 7:00 am |
RNS |
Tiziana Life Sciences to Host Investor Update Call |
| 18th Nov 2020 2:00 pm |
RNS |
Director/PDMR Shareholding |
| 11th Nov 2020 7:00 am |
RNS |
Phase 1b/2 Clinical Trial - Crohn's Disease |
